Catalyst Wire Dossier Catalyst Wire Dossier

SKP-1041

· Somnus Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SKP-1041, covering 2013-02-01 to 2013-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of Sleep-maintenance Activity of 3 Doses of SKP-1041 [Phase 2]

See pricing